You are here

PhaseBio

PhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy Code

Yahoo Finance

Mon, 10/24/22 - 12:10 pm

PhaseBio’s Reversal Agent for Astra’s Brilinta could Spell Success for Both

BioSpace

Thu, 06/23/22 - 10:32 am

antiplatelet therapy

PhaseBio Reversal Agent Continues to Show Promise in Phase III

BioSpace

Mon, 11/15/21 - 11:46 pm

clinical trials

bloodthinner reversals

PhaseBio gets FDA nod to begin Covid-19 trial with VIP receptor agonist PB1046

Pharmaceutical Business Review

Thu, 05/28/20 - 10:33 am

clinical trials

PhaseBio touts 'breakthrough' badge for bloodthinner reversal agent licensed from AstraZeneca, shares leap

Endpoints

Tue, 04/9/19 - 08:22 am

bloodthinner reversals

breakthrough status

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings

Yahoo/Benzinga

Sat, 03/16/19 - 12:25 pm

SAGE Therapeutics

Ligand Pharmaceuticals

Jazz Pharmaceuticals

Lexicon Pharmaceuticals

Leap Therapeutics

PhaseBio, Osmotica price IPOs well below range

BioCentury

Thu, 10/18/18 - 11:47 pm

Osmotica Pharmaceuticals

PhaseBio details dollars in AstraZeneca deal as it rolls out a plan for $86M-plus IPO

Endpoints

Mon, 09/24/18 - 09:44 am

anti-anti-coagulants

AstraZeneca gambles on a $40M round for diabetes/cardio biotech PhaseBio

Fierce Biotech

Thu, 03/12/15 - 10:44 am